Key Publications February 9, 2018

Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trial.

J Lipid Res. 2017;58:2180-2187

Koopal C, Marais AD, Westerink J, van der Graaf Y, Visseren FLJ